Micronutrient therapy for pyrroluria: a retrospective analysis of patient acceptance
Archives of Gynecology and Obstetrics · 06.01.2026 · 313 (1)
DOI: 10.1007/s00404-025-08252-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 06.01.2026. Verfasst von Lena Zingg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Micronutrients, Patient Acceptance of Health Care. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bern.
Abstract (Originalsprache)
Purpose
Pyrroluria is a proposed metabolic condition that remains controversial and insufficiently supported by empirical evidence within conventional medical practice and research. The present study evaluates patient acceptance of micronutrient therapy prescribed for pyrroluria in a clinical setting. The aim is not to validate the condition but to document patient experiences with a therapy commonly used in complementary practice.
Methods
This retrospective cohort study was conducted in the Department of Gynecology at the University Hospital of Bern in 2022/2023. The study included patients who tested positive for pyrroluria and received micronutrient therapy. The primary outcome was the overall acceptance of therapy, assessed using the validated ACCEPT© questionnaire.
Results
The mean score for overall therapy acceptance was 74 ± 34 out of a maximum of 100 points, indicating a high level of acceptance. Micronutrient therapy was also well accepted in terms of side effects (85 ± 27), treatment constraints (71 ± 24), long-term use (85 ± 20), and therapy regimen (84 ± 21). The perceived efficacy of the therapy received a score of 63 ± 34, which did not reach statistical significance (p = 0.7).
Conclusions
Micronutrient therapy was well tolerated and accepted by patients with pyrroluria, underscoring its potential as a low-risk adjunctive intervention. However, the perceived treatment efficacy was modest, and no conclusions about the biological validity of pyrroluria or the effectiveness of the therapy can be drawn. Rigorous, placebo-controlled trials are needed to evaluate the therapeutic value of micronutrients in this context. Furthermore, substantial scientific investigation is required to determine whether pyrroluria constitutes a valid clinical entity within conventional medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Bern, Bern, Switzerland.
- Department of Obstetrics and Gynecology, University Hospital of Bern, Bern, Schweiz.
- Graduate School for Health Sciences, University of Bern, Bern, Schweiz.
- Freelance Statistician "Statistics - analysis, Consulting, Training", Chemnitz, Germany.
- Department of Obstetrics and Gynecology, University Hospital of Bern, Bern, Schweiz. petra.stute@insel.ch.
ORCID-Profile: Elena Pavicic, Norman Bitterlich, Petra Stute
Förderung
- University of Bern
Zitieren
APA
Zingg, L., Pavicic, E., Bitterlich, N., & Stute, P. (2026). Micronutrient therapy for pyrroluria: a retrospective analysis of patient acceptance. Archives of Gynecology and Obstetrics, 313(1). https://doi.org/10.1007/s00404-025-08252-8
Vancouver
Zingg L, Pavicic E, Bitterlich N, Stute P. Micronutrient therapy for pyrroluria: a retrospective analysis of patient acceptance. Archives of Gynecology and Obstetrics. 2026;313(1). doi:10.1007/s00404-025-08252-8
BibTeX
@article{Zingg2026,
author = {Zingg, Lena and Pavicic, Elena and Bitterlich, Norman and Stute, Petra},
title = {Micronutrient therapy for pyrroluria: a retrospective analysis of patient acceptance},
journal = {Archives of Gynecology and Obstetrics},
year = {2026},
volume = {313},
number = {1},
doi = {10.1007/s00404-025-08252-8}
}
EUVIMED